Myriad Genetics, Inc (NASDAQ:MYGN) Is Now 11.22% Above Its 52-Week Low. How Long Will It Continue To Rise?
In last trading session, Myriad Genetics, Inc (NASDAQ:MYGN) saw 0.36 million shares changing hands with its beta currently measuring 1.89. Company’s recent per share price